Dergi makalesi Açık Erişim
Kolukisa, Burcu; Baser, Dilek; Akcam, Bengu; Danielson, Jeffrey; Eltan, Sevgi Bilgic; Haliloglu, Yesim; Sefer, Asena Pinar; Babayeva, Royale; Akgun, Gamze; Charbonnier, Louis-Marie; Schmitz-Abe, Klaus; Demirkol, Yasemin Kendir; Zhang, Yu; Gonzaga-Jauregui, Claudia; Heredia, Raul Jimenez; Kasap, Nurhan; Kiykim, Ayca; Yucel, Esra Ozek; Gok, Veysel; Unal, Ekrem; Unal, Ekrem
{ "conceptrecid": "235245", "created": "2022-10-07T09:16:27.115263+00:00", "doi": "10.1111/all.15010", "files": [ { "bucket": "e0d7dbb4-c398-4e91-a033-d371c7760fd4", "checksum": "md5:c1a1e64ba2b8e25122f7b16dff885a67", "key": "bib-358244b9-5f0b-461d-9059-26b7f13378a9.txt", "links": { "self": "https://aperta.ulakbim.gov.tr/api/files/e0d7dbb4-c398-4e91-a033-d371c7760fd4/bib-358244b9-5f0b-461d-9059-26b7f13378a9.txt" }, "size": 384, "type": "txt" } ], "id": 235246, "links": { "badge": "https://aperta.ulakbim.gov.tr/badge/doi/10.1111/all.15010.svg", "bucket": "https://aperta.ulakbim.gov.tr/api/files/e0d7dbb4-c398-4e91-a033-d371c7760fd4", "doi": "https://doi.org/10.1111/all.15010", "html": "https://aperta.ulakbim.gov.tr/record/235246", "latest": "https://aperta.ulakbim.gov.tr/api/records/235246", "latest_html": "https://aperta.ulakbim.gov.tr/record/235246" }, "metadata": { "access_right": "open", "access_right_category": "success", "communities": [ { "id": "tubitak-destekli-proje-yayinlari" } ], "creators": [ { "name": "Kolukisa, Burcu" }, { "name": "Baser, Dilek" }, { "name": "Akcam, Bengu" }, { "name": "Danielson, Jeffrey" }, { "name": "Eltan, Sevgi Bilgic" }, { "affiliation": "Erciyes Univ, Dept Med Biol, Sch Med, Kayseri, Turkey", "name": "Haliloglu, Yesim" }, { "name": "Sefer, Asena Pinar" }, { "name": "Babayeva, Royale" }, { "name": "Akgun, Gamze" }, { "name": "Charbonnier, Louis-Marie" }, { "affiliation": "Harvard Med Sch, Boston Childrens Hosp, Div Immunol & Newborn Med, Boston, MA 02115 USA", "name": "Schmitz-Abe, Klaus" }, { "affiliation": "Univ Hlth Sci, Umraniye Teaching & Res Hosp, Genom Lab GLAB, Istanbul, Turkey", "name": "Demirkol, Yasemin Kendir" }, { "name": "Zhang, Yu" }, { "affiliation": "Regeneron Genet Ctr, Tarrytown, NY USA", "name": "Gonzaga-Jauregui, Claudia" }, { "name": "Heredia, Raul Jimenez" }, { "name": "Kasap, Nurhan" }, { "affiliation": "Istanbul Univ Cerrahpasa, Fac Med Pediat Allergy & Immunol, Istanbul, Turkey", "name": "Kiykim, Ayca" }, { "affiliation": "Istanbul Univ, Istanbul Fac Med Pediat Allergy & Immunol, Istanbul, Turkey", "name": "Yucel, Esra Ozek" }, { "affiliation": "Erciyes Univ, Sch Med Pediat Hematol & Oncol, Kayseri, Turkey", "name": "Gok, Veysel" }, { "affiliation": "Erciyes Univ, Sch Med Pediat Hematol & Oncol, Kayseri, Turkey", "name": "Unal, Ekrem" }, { "affiliation": "Erciyes Univ, Sch Med Pediat Hematol & Oncol, Kayseri, Turkey", "name": "Unal, Ekrem" } ], "description": "Background Biallelic loss-of-function mutations in CARMIL2 cause combined immunodeficiency associated with dermatitis, inflammatory bowel disease (IBD), and EBV-related smooth muscle tumors. Clinical and immunological characterizations of the disease with long-term follow-up and treatment options have not been previously reported in large cohorts. We sought to determine the clinical and immunological features of CARMIL2 deficiency and long-term efficacy of treatment in controlling different disease manifestations. Methods The presenting phenotypes, long-term outcomes, and treatment responses were evaluated prospectively in 15 CARMIL2-deficient patients, including 13 novel cases. Lymphocyte subpopulations, protein expression, regulatory T (Treg), and circulating T follicular helper (cT(FH)) cells were analyzed. Three-dimensional (3D) migration assay was performed to determine T-cell shape. Results Mean age at disease onset was 38 +/- 23 months. Main clinical features were skin manifestations (n = 14, 93%), failure to thrive (n = 10, 67%), recurrent infections (n = 10, 67%), allergic symptoms (n = 8, 53%), chronic diarrhea (n = 4, 27%), and EBV-related leiomyoma (n = 2, 13%). Skin manifestations ranged from atopic and seborrheic dermatitis to psoriasiform rash. Patients had reduced proportions of memory CD4(+) T cells, Treg, and cT(FH) cells. Memory B and NK cells were also decreased. CARMIL2-deficient T cells exhibited reduced T-cell proliferation and cytokine production following CD28 co-stimulation and normal morphology when migrating in a high-density 3D collagen gel matrix. IBD was the most severe clinical manifestation, leading to growth retardation, requiring multiple interventional treatments. All patients were alive with a median follow-up of 10.8 years (range: 3-17 years). Conclusion This cohort provides clinical and immunological features and long-term follow-up of different manifestations of CARMIL2 deficiency.", "doi": "10.1111/all.15010", "has_grant": false, "journal": { "issue": "3", "pages": "1004-1019", "title": "ALLERGY", "volume": "77" }, "license": { "id": "cc-by" }, "publication_date": "2022-01-01", "relations": { "version": [ { "count": 1, "index": 0, "is_last": true, "last_child": { "pid_type": "recid", "pid_value": "235246" }, "parent": { "pid_type": "recid", "pid_value": "235245" } } ] }, "resource_type": { "subtype": "article", "title": "Dergi makalesi", "type": "publication" }, "science_branches": [ "Di\u011fer" ], "title": "Evolution and long-term outcomes of combined immunodeficiency due to CARMIL2 deficiency" }, "owners": [ 1 ], "revision": 1, "stats": { "downloads": 4.0, "unique_downloads": 4.0, "unique_views": 46.0, "version_downloads": 4.0, "version_unique_downloads": 4.0, "version_unique_views": 46.0, "version_views": 47.0, "version_volume": 1536.0, "views": 47.0, "volume": 1536.0 }, "updated": "2022-10-07T09:16:27.162779+00:00" }
Görüntülenme | 47 |
İndirme | 4 |
Veri hacmi | 1.5 kB |
Tekil görüntülenme | 46 |
Tekil indirme | 4 |